Newton One Investments’s Maravai LifeSciences MRVI Stock Holding History

Newton One Investments’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-35	Closed	-$1K	–	127
2021 Q4	$1K	Hold	35	–	–	﹤0.01%	127
2021 Q3	$2K	Buy	+35	New	+$1.71K	﹤0.01%	119

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Newton One Investments's MRVI Position: Q1 2022 in Review

Newton One Investments sold out of Maravai LifeSciences (MRVI) in Q1 2022, closing a stake of 35 shares — an estimated $1K sold.

Newton One Investments first reported a position in MRVI in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 235 funds tracked by Wall St. Rank hold MRVI as of Q1 2022.

Newton One Investments reported no remaining Maravai LifeSciences position as of Q1 2022 after selling out during the quarter.
Newton One Investments sold 35 Maravai LifeSciences shares in Q1 2022, an estimated $1K.
Newton One Investments first reported a position in Maravai LifeSciences in Q3 2021 and held it in 2 quarters.
Newton One Investments's Maravai LifeSciences position peaked at $2K in Q3 2021.
235 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2022.

Based on Newton One Investments's 13F filing for Q1 2022, filed 28 Apr 2022.